VERADIGM INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-09-15: Form 8-K; Period of report 2026-09-15; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2026-09-08: Form 8-K; Period of report 2026-09-08; Description 8.01 Other Events; Details 8.01.
- 2026-09-08: Form 8-K; Period of report 2026-09-08; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2026-08-17: Form 8-K; Period of report 2026-08-17; Description 7.01 Regulation FD Disclosure; Details 7.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2026-09-15 | 8-K | 2026-09-15 | 7.01 Regulation FD Disclosure | 7.01 As previously announced, the Company will present at the 2026 Jefferies Healthcare Services and Technology Conference in Nashville, Tennessee on September 15, 2026 and will participate in the Deutsche Bank 2026 Healthcare Summit in New York, New York on September 16, 2026. | mdrx-20260915.htm |
| 2026-09-08 | 8-K | 2026-09-08 | 8.01 Other Events | 8.01 Veradigm Inc. (the “Company”) recently learned that one of its third-party vendors experienced a cybersecurity incident that impacted certain data associated with a small number of the Company’s customers. | mdrx-20260908.htm |
| 2026-09-08 | 8-K | 2026-09-08 | 7.01 Regulation FD Disclosure | 7.01 As previously disclosed, on August 17, 2026, the Company announced that members of the Company's management would participate in the 2026 Jefferies Healthcare Services and Technology Conference in Nashville, Tennessee on September 15, 2026 and the Deutsche Bank 2026 Healthcare Summit in New York, New York on September 16, 2026. | mdrx-20260908.htm |
| 2026-08-17 | 8-K | 2026-08-17 | 7.01 Regulation FD Disclosure | 7.01 On August 17, 2026, the Company issued a press release announcing that members of the Company's management will participate in two investor conferences in September 2026. | mdrx-20260817.htm |
| 2026-06-26 | 8-K | 2026-06-25 | 8.01 Other Events | 8.01 As previously disclosed, on July 26, 2024, Veradigm Inc. (the “Company”) entered into a Stockholder Agreement (the “Stockholder Agreement”) with Charles Myers (“Myers”) and Jessica Myers (together with Myers, the “Myers Parties”), pursuant to which Myers serves as an observer of the board of directors of the Company (the “Board”). | mdrx-20260625.htm |
| 2026-05-26 | 8-K/A | 2026-03-31 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On April 6, 2026, Veradigm Inc. (the “Company”) filed a Current Report on Form 8-K (the “Initial Form 8-K”) to announce, among other things, that Leland Westerfield, the Company’s then-Interim Chief Financial Officer, principal financial officer and principal accounting officer, would continue serving the Company as a consultant following the termination of his employment with the Company, subject to execution of a mutually agreeable consulting agreement with the Company. | mdrx-20260331.htm |
| 2026-05-26 | 8-K | 2026-05-26 | 2.02 Results of Operations and Financial Condition | 2.02 On May 26, 2026, Veradigm Inc. (the “Company”) issued a press release announcing the filing of its comprehensive Annual Report on Form 10-K for the fiscal years ended December 31, 2023 and December 31, 2024 (the “2023 and 2024 Form 10-K”) with the U.S. Securities and Exchange Commission. | mdrx-20260526.htm |
| 2026-04-06 | 8-K | 2026-03-31 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure | 5.02 On April 6, 2026, Veradigm Inc. (the “Company”) announced the appointment of Christian Greyenbuhl as the Company’s new Chief Financial Officer, effective as of the later of (a) May 11, 2026 and (b) the first business day following the date that the Company files its Annual Report on Form 10-K for its 2023 and 2024 fiscal years, or as otherwise agreed (such later date, the “Effective Date”). 7.01 On April 6, 2026, the Company issued a press release announcing the appointment of Mr. Greyenbuhl to serve as the Company’s Chief Financial Officer. | d69521d8k.htm |
| 2026-02-24 | 8-K | 2026-02-20 | 8.01 Other Events | 8.01 On February 20, 2026, Veradigm Inc. (the “Company”) received a letter from the Division of Enforcement of the U.S. Securities and Exchange Commission (the “SEC”) stating that it has concluded its investigation as to the Company and, based on the information available as of the date of the letter, it does not intend to recommend an enforcement action. | mdrx-20260220.htm |
| 2026-02-17 | 8-K | 2026-02-17 | 2.02 Results of Operations and Financial Condition | 2.02 On February 17, 2026, Veradigm Inc., a Delaware corporation (the “Company”), announced that it has provided preliminary estimated, unaudited ranges of GAAP revenue for the fiscal years ended December 31, 2024 and 2025 and preliminary estimated, unaudited cash and debt positions as of December 31, 2024 and December 31, 2025, along with certain other financial information (collectively, the “Financial Information”). | mdrx-20260217.htm |
| 2026-02-02 | 8-K | 2026-02-02 | 1.01 Entry into a Material Definitive Agreement; 3.03 Material Modification to Rights of Security Holders; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 3.03 The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated into this Item 3.03 by reference. 7.01 On February 2, 2026, the Company issued a press release announcing the amendment of the Rights Agreement. | d58659d8k.htm |
| 2026-01-20 | 8-K | 2026-01-15 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | mdrx-20260115.htm |